Your browser doesn't support javascript.
loading
How do they add up? The interaction between the placebo and treatment effect: A systematic review.
Boussageon, Rémy; Howick, Jeremy; Baron, Raphael; Naudet, Florian; Falissard, Bruno; Harika-Germaneau, Ghina; Wassouf, Issa; Gueyffier, François; Jaafari, Nemat; Blanchard, Clara.
Afiliación
  • Boussageon R; Laboratoire de Biométrie et Biologie Evolutive, Equipe Evaluation et modélisation des effets thérapeutiques, Lyon, France.
  • Howick J; Faculty of Philosophy, University of Oxford, Radcliffe Infirmary Quarter, Oxford, UK.
  • Baron R; Collège Universitaire de Médecine Générale, University of Lyon, Lyon, France.
  • Naudet F; University of Rennes 1, Rennes, France.
  • Falissard B; CESP/INSERM U1018 (Centre de Recherche en Epidemiologie et Santé des Populations), Paris, France.
  • Harika-Germaneau G; Unité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.
  • Wassouf I; Unité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.
  • Gueyffier F; Laboratoire de Biométrie et Biologie Evolutive, Equipe Evaluation et modélisation des effets thérapeutiques, Lyon, France.
  • Jaafari N; Unité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.
  • Blanchard C; Department of General Practice, University of Poitiers, Poitiers, France.
Br J Clin Pharmacol ; 88(8): 3638-3656, 2022 08.
Article en En | MEDLINE | ID: mdl-35384004
ABSTRACT

AIM:

The placebo effect and the specific effect are often thought to add up (additive model). Whether additivity holds can dramatically influence the external validity of a trial. This assumption of additivity was tested by Kleijnen et al in 1994 but the data produced since then have not been synthetized. In this review, we aimed to systematically review the literature to determine whether additivity held.

METHODS:

We searched Medline and PsychInfo up to 10 January 2019. Studies using the balanced placebo design (BPD), testing two different strengths of placebos, were included. The presence of interaction was evaluated by comparing each group in the BPD with analysis of variance or covariance.

RESULTS:

Thirty studies were included and the overall risk of bias was high four found evidence of additivity and 16 studies found evidence of interaction (seven had evidence of positive additivity).

CONCLUSION:

Evidence of additivity between placebo and specific features of treatments was rare in included studies. We suggest interventions for placebo-sensitive ailments should be tested in trials designed to take interactions seriously once an exploratory RCTs has proven their efficacy with sufficient internal validity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Efecto Placebo Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Efecto Placebo Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Francia